Trial Outcomes & Findings for The Evaluation of a Mask for the Treatment of Obstructive Sleep Apnea (NCT NCT03142438)

NCT ID: NCT03142438

Last Updated: 2021-07-14

Results Overview

Usability reported from participants questionnaires to evaluate the use of the F\&P mask for treatment of Obstructive Sleep Apnea

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

57 participants

Primary outcome timeframe

14 ± 4 days in-Home

Results posted on

2021-07-14

Participant Flow

Participant milestones

Participant milestones
Measure
F&P Seal Improvement Project
participants will be placed on this arm for a total of 14 +- 4 days from visit 1. participants will be using the trial mask during this treatment arm F\&P Seal Improvement Project: Participants will be placed on this arm for a total 14 ± 4 days from Visit 1. Participants will be using the trial full face or nasal mask during this treatment arm.
Overall Study
STARTED
57
Overall Study
COMPLETED
57
Overall Study
NOT COMPLETED
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

The Evaluation of a Mask for the Treatment of Obstructive Sleep Apnea

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
F&P Seal Improvement Project
n=57 Participants
participants will be placed on this arm for a total of 14 +- 4 days from visit 1. participants will be using the trial mask during this treatment arm F\&P Seal Improvement Project: Participants will be placed on this arm for a total 14 ± 4 days from Visit 1. Participants will be using the trial full face or nasal mask during this treatment arm.
Age, Customized
22 or older
57 Participants
n=93 Participants
Sex: Female, Male
Female
19 Participants
n=93 Participants
Sex: Female, Male
Male
38 Participants
n=93 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
5 Participants
n=93 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
52 Participants
n=93 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=93 Participants
Region of Enrollment
United States
52 Participants
n=93 Participants
Region of Enrollment
New Zealand
5 Participants
n=93 Participants

PRIMARY outcome

Timeframe: 14 ± 4 days in-Home

Usability reported from participants questionnaires to evaluate the use of the F\&P mask for treatment of Obstructive Sleep Apnea

Outcome measures

Outcome measures
Measure
F&P Seal Improvement Project
n=57 Participants
participants will be placed on this arm for a total of 14 +- 4 days from visit 1. participants will be using the trial mask during this treatment arm F\&P Seal Improvement Project: Participants will be placed on this arm for a total 14 ± 4 days from Visit 1. Participants will be using the trial full face or nasal mask during this treatment arm.
Number of Participants Subjective Usability Reporting
Easier
14 Participants
Number of Participants Subjective Usability Reporting
The same
41 Participants
Number of Participants Subjective Usability Reporting
More difficult
2 Participants

PRIMARY outcome

Timeframe: 14 ± 4 days in-Home

Comfort reported from participants questionnaires to evaluate the use of the F\&P mask for treatment of Obstructive Sleep Apnea compared to usual

Outcome measures

Outcome measures
Measure
F&P Seal Improvement Project
n=57 Participants
participants will be placed on this arm for a total of 14 +- 4 days from visit 1. participants will be using the trial mask during this treatment arm F\&P Seal Improvement Project: Participants will be placed on this arm for a total 14 ± 4 days from Visit 1. Participants will be using the trial full face or nasal mask during this treatment arm.
Number or Participants Comparative Subjective Reported Comfort
More comfortable
27 Participants
Number or Participants Comparative Subjective Reported Comfort
The same
24 Participants
Number or Participants Comparative Subjective Reported Comfort
Less comfortable
6 Participants

SECONDARY outcome

Timeframe: 14 ± 4 days in-Home

Objective Apnea-Hypopnea Index (AHI) data recorded from the positive airway pressure (PAP) device to evaluate the use of the F\&P mask for treatment of Obstructive Sleep Apnea

Outcome measures

Outcome measures
Measure
F&P Seal Improvement Project
n=57 Participants
participants will be placed on this arm for a total of 14 +- 4 days from visit 1. participants will be using the trial mask during this treatment arm F\&P Seal Improvement Project: Participants will be placed on this arm for a total 14 ± 4 days from Visit 1. Participants will be using the trial full face or nasal mask during this treatment arm.
Objective Performance Reporting
Lower AHI
17 Participants
Objective Performance Reporting
No change in AHI
3 Participants
Objective Performance Reporting
Higher AHI
8 Participants
Objective Performance Reporting
Not collected
29 Participants

SECONDARY outcome

Timeframe: 14 ± 4 days in-Home

Acceptability reported from participants questionnaires to evaluate the use of the F\&P mask for treatment of Obstructive Sleep Apnea

Outcome measures

Outcome measures
Measure
F&P Seal Improvement Project
n=57 Participants
participants will be placed on this arm for a total of 14 +- 4 days from visit 1. participants will be using the trial mask during this treatment arm F\&P Seal Improvement Project: Participants will be placed on this arm for a total 14 ± 4 days from Visit 1. Participants will be using the trial full face or nasal mask during this treatment arm.
Number of Participants Reported Mask Acceptability
Happy to use improved
27 Participants
Number of Participants Reported Mask Acceptability
Not happy to use improved
18 Participants
Number of Participants Reported Mask Acceptability
Happy to use either
12 Participants

SECONDARY outcome

Timeframe: 14 ± 4 days in-Home

Comfort reported from participants questionnaires to evaluate the use of the F\&P mask for treatment of Obstructive Sleep Apnea

Outcome measures

Outcome measures
Measure
F&P Seal Improvement Project
n=57 Participants
participants will be placed on this arm for a total of 14 +- 4 days from visit 1. participants will be using the trial mask during this treatment arm F\&P Seal Improvement Project: Participants will be placed on this arm for a total 14 ± 4 days from Visit 1. Participants will be using the trial full face or nasal mask during this treatment arm.
Number of Participants Subjective Comfort Reporting
Very comfortable
35 Participants
Number of Participants Subjective Comfort Reporting
Comfortable
16 Participants
Number of Participants Subjective Comfort Reporting
Neither comfortable or uncomfortable
4 Participants
Number of Participants Subjective Comfort Reporting
Uncomfortable
2 Participants
Number of Participants Subjective Comfort Reporting
Very uncomfortable
0 Participants

SECONDARY outcome

Timeframe: 14 ± 4 days in-Home

Seal performance reported from participants questionnaires to evaluate the use of the F\&P mask for treatment of Obstructive Sleep Apnea

Outcome measures

Outcome measures
Measure
F&P Seal Improvement Project
n=57 Participants
participants will be placed on this arm for a total of 14 +- 4 days from visit 1. participants will be using the trial mask during this treatment arm F\&P Seal Improvement Project: Participants will be placed on this arm for a total 14 ± 4 days from Visit 1. Participants will be using the trial full face or nasal mask during this treatment arm.
Number or Participants Subjective Reporting of Seal Performance
Very good
28 Participants
Number or Participants Subjective Reporting of Seal Performance
Good
22 Participants
Number or Participants Subjective Reporting of Seal Performance
Neither good nor poor
6 Participants
Number or Participants Subjective Reporting of Seal Performance
Poor
1 Participants
Number or Participants Subjective Reporting of Seal Performance
Very poor
0 Participants

Adverse Events

F&P Seal Improvement Project

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Hanie Yee

Fisher & Paykel Healthcare

Phone: +64 9 574 0123

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place